1. The impact of phlebotomy and hydroxyurea on survival and risk of thrombosis among older patients with polycythemia vera
by Nikolai A. Podoltsev, Mengxin Zhu, Amer M. Zeidan, Rong Wang, Xiaoyi Wang, Amy J. Davidoff, Scott F. Huntington, Smith Giri, Steven D. Gore, and Xiaomei Ma
BloodAdv
Volume 2(20):
October 23, 2018
© 2018 by The American Society of Hematology

2. Nikolai A. Podoltsev et al. Blood Adv 2018;2:2681-2690
© 2018 by The American Society of Hematology

3. Cohort selection criteria.
Nikolai A. Podoltsev et al. Blood Adv 2018;2:
© 2018 by The American Society of Hematology

4. Phlebotomy and HU use among 820 PV patients.
Nikolai A. Podoltsev et al. Blood Adv 2018;2:
© 2018 by The American Society of Hematology

5. Kaplan-Meier curves for overall survival.
Kaplan-Meier curves for overall survival. (A) By phlebotomy use. (B) By HU use.
Nikolai A. Podoltsev et al. Blood Adv 2018;2:
© 2018 by The American Society of Hematology

6. Kaplan-Meier curves for thrombosis after diagnosis.
Kaplan-Meier curves for thrombosis after diagnosis. (A) By phlebotomy use. (B) By HU use.
Nikolai A. Podoltsev et al. Blood Adv 2018;2:
© 2018 by The American Society of Hematology